26 results
8-K
EX-99.1
RNLX
Renalytix Plc
10 Jan 24
Regulation FD Disclosure
7:15am
27% black patients, demonstrate that electronic health record deployment of KidneyIntelX in vitro prognostic testing was associated with clinical … (a) patient median baseline age of 68 years (b) 27% Black, (c) median BMI of 30 (d) evidence of hypertension in 89% of subjects and (e) 9% with stage A-D
10-Q
2024 Q1
RNLX
Renalytix Plc
14 Nov 23
Quarterly report
12:00am
. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model, which requires inputs based … and development
General and administrative
Cost of revenue
The fair value of options is estimated using the Black-Scholes option pricing model, which
DEFR14A
RNLX
Renalytix Plc
13 Nov 23
Revised proxy
5:15pm
of Directors Based on Gender Identity
Part 2: Demographic Information
African American or Black
Alaskan Native or American Indian
Asian
Hispanic or Latinx
DEF 14A
3dv7kinnkn4f6l
13 Nov 23
Definitive proxy
9:22am
PRE 14A
httad13ywp571an
3 Nov 23
Preliminary proxy
4:04pm
8-K
EX-99.1
ny67 s7qnf
28 Sep 23
Renalytix Reports Full Year Fiscal 2023 Results
7:31am
10-K
yy3yiv8dtk
28 Sep 23
Annual report
6:18am
6-K
8br6cs vet
9 Jun 23
Current report (foreign)
7:01am
6-K
ctvyzh2dg jh4
30 Mar 23
Current report (foreign)
7:01am
6-K
8dhs77 hv9y
30 Nov 22
Current report (foreign)
7:31am
6-K
EX-99.1
gjmeo1cpkgn
22 Nov 22
Annual Report and For the Year Ended 30 June 2022
5:09pm
20-F/A
oyi1b8u
1 Aug 22
Annual report (foreign) (amended)
4:54pm
6-K
gyxe9 kc9j4t
30 Jun 22
Current report (foreign)
7:01am
6-K/A
a4oxdk44sgftv5feri8
29 Apr 22
Current report (foreign) (amended)
4:58pm
6-K
EX-99.1
beeju59vo6z4j82y
31 Mar 22
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022
7:00am
6-K
EX-99.1
qje oomcf
7 Dec 21
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
4:05pm
6-K
EX-99.1
yd466o4tko4k2r9
30 Nov 21
Renalytix plc Annual Report and Financial Statements FOR THE YEAR ENDED 30 JUNE 2021
4:15pm